Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease

E. Panagiotopoulou, I. E. Triantaphyllidou, S. Fouzas, K. N. Priftis, N. Karamanos, M. B. Anthracopoulos (Patras, Athens, Greece)

Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Panagiotopoulou, I. E. Triantaphyllidou, S. Fouzas, K. N. Priftis, N. Karamanos, M. B. Anthracopoulos (Patras, Athens, Greece). Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease. Eur Respir J 2010; 36: Suppl. 54, 3467

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Relationship between IL-8, IL-10, MMP-9 and morphological findings in BAL fluid of patients with interstitial lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 225s
Year: 2003

Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008


CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL
Source: Eur Respir J 2005; 26: Suppl. 49, 298s
Year: 2005

Inflammatory and regulatory cytokine IL-6 in plasma and BAL fluid of patients with pulmonary sarcoidosis
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Evaluation in bronchoalveolar lavage fluid (BALF) of cytokines TNF-alpha, IL-6 and IL-8 in children with severe bronchial asthma (BA)
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010

Determination of CD4, CD8 and IL-8 levels in serum and BAL fluid of patients with pulmonary anthracosis
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Different concentrations of CCL18 in serum and BALF of ILDs: A marker of pulmonary inflammation?
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Comparison of differential cell counts and interleukin-8 levels in bronchoalveolar lavage and induced sputum from lung transplant recipients
Source: Eur Respir J 2003; 22: Suppl. 45, 201s
Year: 2003

Increased activin-a expression in serum, BAL and bronchial tissue of asthmatic patients
Source: Annual Congress 2009 - Novel approaches in asthma
Year: 2009


Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001

The expression of IL-5, GM-CSF mRNA and its modulation by dexamethasone in lung tissue and esoinohils of bronchoalveolar lavage fluid from allergic guinea-pigs
Source: Eur Respir J 2001; 18: Suppl. 33, 272s
Year: 2001

Cellular changes in BAL fluid may reflect immunity in patients with lung cancer
Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression
Year: 2005

Levels of tumour necrosis factor and interferon in bronchoalveolar lavage fluid and blood serum in children with chronic bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 530s
Year: 2001

HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Main features of cytokine profile in serum and bronchoalveolar lavage fluid in patients with recurrent sarcoidosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013

Extracorporal photosensitation in bleomycin-induced lung injury decreases IL-10 protein levels in BAL but not the level of inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 82s
Year: 2005

Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002